In the Media: Dementia – Coping With Common, Sometimes Distressing Behaviors
Drs. Stephanie Collier and Lydia Cho offer strategies for coping with dementia-related behaviors.
Alzheimer’s Disease Related Content
In the Media: Alzheimer’s Drug Donanemab – What a Promising Trial Means for Treatments
Dr. Brent P. Forester offers feedback regarding the results of a new Alzheimer’s disease drug trial.
Video: Helping Older Adults Manage Alzheimer’s and Other Dementias
It’s a fact of life that our brains change as we grow older, and as they do, we might notice some subtle differences in the way they work. Aging adults are often increasingly prone to misplacing items or struggling to recall something from the past, for example. These shifts are natural and pose no...
In the Media: Why Experts Say a Promising New Alzheimer’s Drug Is Different
Watch Dr. Brent P. Forester explain how a new Alzheimer’s disease treatment is different than other Alzheimer’s medications.
Everything You Need To Know About Older Adult Mental Health
The world is aging. According to the World Health Organization, we can expect the over-60 population to double worldwide between 2015 and 2050. Considering 15% of these individuals struggle with some form of mental health disorder, and that neurological and mental issues account for more than 6% of...
In the Media: Heralded Alzheimer’s Drug Works – But Safety Concerns Loom
Dr. Brent P. Forester offers feedback to report findings of a new experimental Alzheimer’s disease clinical drug trial.
In the Media: Alzheimer’s Drug Slows Mental Decline in Trial—But Is It a Breakthrough?
Dr. Brent P. Forester comments on the results of a new Alzheimer’s disease drug clinical trial.
In the Media: Promising Alzheimer’s Drug Provides Second Chance for Biogen, and a Debated Theory About the Disease
McLean is part of a new experimental Alzheimer’s disease clinical drug trial.
In the Media: Biogen and Eisai Say Their Second Alzheimer’s Drug Slows the Disease in Large Study
Dr. Brent P. Forester offers feedback about his Alzheimer’s disease drug trial.
In the Media: Can Biogen’s Backup Plan for Alzheimer’s Succeed?
Dr. Brent P. Forester discusses McLean’s clinical trial studying a new, experimental Alzheimer’s disease medication.
In the Media: Dementia – The Epidemic of Our Time
Dr. Brent P. Forester warns that as the “baby boomer” population ages, the U.S. will see a rapid increase in the rate of individuals with neurocognitive disorders.
In the Media: The Challenges to Identifying Dementia, Alzheimer-Risk Patients
Dr. Brent P. Forester stresses the need for improved screening and reinforcement of care at the earliest stages of dementia and Alzheimer’s disease.
In the Media: ‘Some Hope Is Better Than Having No Hope’
Listen to patients from Dr. Brent P. Forester’s Alzheimer’s disease research project discuss their experience with new drug treatments.
In the Media: Doctors Face Dilemma on Whether To Recommend New Alzheimer’s Treatment
“But I also feel hopeful that this attention, focus, and discussion about Alzheimer’s will bring about a lot of change.” – Dr. Brent P. Forester
Family Says Thank You to McLean’s Alzheimer’s Program While Honoring Their Beloved
Rosalie Rudnick collected friends like she collected Caucasian rugs—easily, passionately, and in large numbers. “The world loved Rosalie,” said Mitch, her husband of 60 years. “She was charming and befriended everyone who came near her.” Even after Alzheimer’s disease robbed her of almost everything...
In the Media: Another Upshot of Vaccines: Some Shots Could Help Prevent Alzheimer’s
Dr. Ipsit Vahia and others review the benefits of the COVID-19 vaccine for older adults.
In the Media: I Wrote About Losing My Wife to Younger-Onset Alzheimer’s. This Is What Helped Me Feel Less Alone
Dr. Julie Brody Magid and other experts comment on the grief caregivers struggle with while caring for loved ones with Alzheimer’s disease.
Study Will Enhance Training for Nurses Working With Dementia Patients
McLean Hospital’s Brent P. Forester, MD, MSc, is heading a new study of a training model to help primary care nurses better care for patients with dementia. Funded by a $54 million grant from the National Institute on Aging (NIA), the research effort is one of two pilot studies by the NIA’s IMPACT...
Video: Dr. Brent Forester on Alzheimer’s Disease in 2020
Dr. Brent Forester, chief of McLean’s Division of Geriatric Psychiatry, shares an update on the evaluation and management of Alzheimer’s Disease and related disorders and what’s new in 2020.
Video: Keith Fargo Offers the View From the Alzheimer’s Association (TIPS 2019)
Keith Fargo, PhD, Alzheimer’s Association, presents View From the Alzheimer’s Association, as part of the panel Digital Mental Health and Aging: Emerging Perspectives. These remarks were part of the 2019 Technology in Psychiatry Summit, an event sponsored by the McLean Institute for Technology in...
